Rankings
▼
Calendar
MESO FY 2015 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena
MESO
Mesoblast Limited
$2B
FY 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$24M
-8.6% YoY
Gross Profit
-$35,000
-0.1% margin
Operating Income
-$113M
-477.5% margin
Net Income
-$119M
-502.6% margin
EPS (Diluted)
$-2.20
Cash Flow
Operating Cash Flow
-$122M
Free Cash Flow
-$124M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$1.0B
Total Liabilities
$409M
Stockholders' Equity
$609M
Cash & Equivalents
$28M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$24M
$26M
-8.6%
Gross Profit
-$35,000
$546,000
-106.4%
Operating Income
-$113M
-$72M
-56.7%
Net Income
-$119M
-$81M
-47.4%
← FY 2014
All Quarters
Q1 2016 →